154 related articles for article (PubMed ID: 18505566)
1. ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells.
Denning K; Smyth P; Cahill S; Li J; Flavin R; Aherne S; O' Leary JJ; Sheils O
Mol Cancer; 2008 May; 7():44. PubMed ID: 18505566
[TBL] [Abstract][Full Text] [Related]
2. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
4. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
[TBL] [Abstract][Full Text] [Related]
5. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
Cahill S; Smyth P; Finn SP; Denning K; Flavin R; O'Regan EM; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
Mol Cancer; 2006 Dec; 5():70. PubMed ID: 17156473
[TBL] [Abstract][Full Text] [Related]
6. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
Powell DJ; Eisenlohr LC; Rothstein JL
J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
Zhu XL; Zhou XY; Zhang TM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
[TBL] [Abstract][Full Text] [Related]
9. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
[TBL] [Abstract][Full Text] [Related]
10. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
Zhu XL; Zhou XY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):270-4. PubMed ID: 16181547
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features.
Durand S; Ferraro-Peyret C; Joufre M; Chave A; Borson-Chazot F; Selmi-Ruby S; Rousset B
Endocr Relat Cancer; 2009 Jun; 16(2):467-81. PubMed ID: 19208736
[TBL] [Abstract][Full Text] [Related]
12. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
[TBL] [Abstract][Full Text] [Related]
14. Real-time analysis of beta- and gamma-catenin mRNA expression in ret/PTC-1 activated and nonactivated thyroid tissues.
Smyth P; Finn S; O'Leary J; Sheils O
Diagn Mol Pathol; 2003 Mar; 12(1):44-9. PubMed ID: 12605035
[TBL] [Abstract][Full Text] [Related]
15. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
Muzza M; Degl'Innocenti D; Colombo C; Perrino M; Ravasi E; Rossi S; Cirello V; Beck-Peccoz P; Borrello MG; Fugazzola L
Clin Endocrinol (Oxf); 2010 May; 72(5):702-8. PubMed ID: 20447069
[TBL] [Abstract][Full Text] [Related]
16. Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms.
Smyth P; Sheils O; Finn S; Martin C; O'Leary J; Sweeney EC
Int J Surg Pathol; 2001 Oct; 9(4):265-72. PubMed ID: 12574841
[TBL] [Abstract][Full Text] [Related]
17. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
[TBL] [Abstract][Full Text] [Related]
18. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
[TBL] [Abstract][Full Text] [Related]
19. RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.
Khan MS; Qadri Q; Makhdoomi MJ; Wani MA; Malik AA; Niyaz M; Masoodi SR; Andrabi KI; Ahmad R; Mudassar S
Pathol Oncol Res; 2020 Jan; 26(1):507-513. PubMed ID: 30467698
[TBL] [Abstract][Full Text] [Related]
20. 20 years of RET/PTC in thyroid cancer: clinico-pathological correlations.
Fusco A; Santoro M
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):731-5. PubMed ID: 17891236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
